Broncus Medical

Broncus Medical has commercialized multiple interventional pulmonology devices globally. Its flagship Archimedes® system provides real-time airway navigation for lung biopsies and interventions. The InterVapor® platform offers a non-surgical vapor ablation therapy for emphysema/COPD, now commercialized in Asia-Pacific markets with ongoing expansion. The company’s RF-II device completed pivotal trials as the first transbronchial interventional product targeting lung cancer, showing safety and efficacy. Other pipeline products include the TLD Radiofrequency Ablation System for COPD exacerbations and new diagnostic needles like BioStar TBNA